Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

LLY

ELI LILLY & Co

Pharmaceutical Preparations · SIC 2834CIK 59478Held by 27 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$65.18B
Net Income FY2025
$20.64B
EPS (Basic, as reported)
$23.00
Net Margin FY2025
31.7%
ROE FY2025
77.8%
Total Equity
$26.54B
Shares Out
941M
Business description

ELI LILLY & Co — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 21,222 → 65,179 +13.3% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue21,22222,87124,55622,32024,54028,31828,54134,12445,04365,179
Cost of revenue(5,710)(6,151)(6,430)(4,721)(5,483)(7,313)(6,630)(7,082)(8,418)(11,052)
Research & development(5,244)(5,282)(5,307)(5,595)(6,086)(7,026)(7,191)———
Selling, general & administrative(6,452)(6,588)(6,632)(6,214)(6,121)(6,432)(6,440)(7,403)(8,594)(11,094)
Interest expense(185)(225)(272)(401)(360)(340)(332)(486)(781)(895)
Interest & investment income10916716180332563174175—
Other income (expense), net(85)52752921,172(202)(321)97(219)(571)
Pre-tax income3,3742,1973,7965,2667,2306,1566,8066,55512,68025,731
Income tax expense(636)(2,401)(564)(628)(1,036)(574)(562)(1,314)(2,090)(5,091)
Net income2,738(204)3,2328,3186,1945,5826,2455,24010,59020,640
EPS — basic$2.59($0.19)$3.14$8.93$6.82$6.15$6.93$5.82$11.76$23.00
EPS — diluted$2.58($0.19)$3.13$8.89$6.79$6.12$6.90$5.80$11.71$22.95
Shares outstanding — basic (M)1,0581,0521,028931908907902900901897
Shares outstanding — diluted (M)1,0621,0521,034936913912905903904899

Showing the latest 10 of 19 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.